Evidence map›Paper›PMID 29098737›Full record

ArticleHuman mutation2018

Structural and functional differences in PHOX2B frameshift mutations underlie isolated or syndromic congenital central hypoventilation syndrome.

Simona Di Lascio, Roberta Benfante, Eleonora Di Zanni, Silvia Cardani, Annalisa Adamo, Diego Fornasari, Isabella Ceccherini, Tiziana Bachetti

Open access · hybridAbstract read
In one paragraph

Article in Human mutation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. CRISPR/Cas9-mediatedFrontiers in physiology · 2026
    Article
  4. Article
  5. TheFrontiers in physiology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. eLife · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. A Novel c.676_677insGJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Simona Di LascioDepartment of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milan, Italy.ORCID 0000-0002-5971-1515
Roberta BenfanteDepartment of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milan, Italy.ORCID 0000-0001-5396-5429
Eleonora Di ZanniUOC Genetica Medica, Istituto Giannina Gaslini, Genoa, Italy.
Silvia CardaniDepartment of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milan, Italy.
Annalisa AdamoUOC Genetica Medica, Istituto Giannina Gaslini, Genoa, Italy.
Diego FornasariDepartment of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milan, Italy.ORCID 0000-0002-9668-3103
Isabella CeccheriniUOC Genetica Medica, Istituto Giannina Gaslini, Genoa, Italy.ORCID 0000-0001-8732-1955
Tiziana BachettiUOC Genetica Medica, Istituto Giannina Gaslini, Genoa, Italy.ORCID 0000-0002-9456-8945
University of Milan · ITIstituto Giannina Gaslini · ITUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heterozygous mutations in the PHOX2B gene are causative of congenital central hypoventilation syndrome (CCHS), a neurocristopathy characterized by defective autonomic control of breathing due to the impaired differentiation of neural crest cells. Among PHOX2B mutations, polyalanine (polyAla) expansions are almost exclusively associated with isolated CCHS, whereas frameshift variants, although less frequent, are often more severe than polyAla expansions and identified in syndromic CCHS. This article provides a complete review of all the frameshift mutations identified in cases of isolated and syndromic CCHS reported in the literature as well as those identified by us and not yet published. These were considered in terms of both their structure, whether the underlying indels induced frameshifts of either 1 or 2 steps ("frame 2" and "frame 3" mutations respectively), and clinical associations. Furthermore, we evaluated the structural and functional effects of one "frame 3" mutation identified in a patient with isolated CCHS, and one "frame 2" mutation identified in a patient with syndromic CCHS, also affected with Hirschsprung's disease and neuroblastoma. The data thus obtained confirm that the type of translational frame affects the severity of the transcriptional dysfunction and the predisposition to isolated or syndromic CCHS.

Indexed as

Electrophoretic Mobility Shift AssayFrameshift MutationHeLa CellsHomeodomain ProteinsHumansHypoventilationMicroscopy, FluorescenceMutationSleep Apnea, CentralTranscription FactorsHomeodomain ProteinsNBPhox proteinTranscription Factorscongenital central hypoventilation syndromedominant-negativeframeshift mutationsgain-of-functionHirschsprung's diseaseloss-of-functionneuroblastomaPHOX2B

Identifiers

PMID29098737
PMCPMC5846889
OpenAlexW2765325391

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.